BioMerieux sees weaker 2014 as forex, investment costs weigh
March 19, 2014 at 03:33 AM EDT
PARIS, March 19 (Reuters) - French diagnostics specialist company BioMerieux said it expected operating income to drop this year as it deals with adverse exchange rates, the integration of U.S. company BioFire, and ongoing production issues at a U.S. plant.
